• Innovation
    Promotion of technological and clinical innovation in critical care
  • Grip
    In-vitro and in-vivo research adherent to clinical practice and relevant for ICU every-day activities
  • Sharing
    International spread of ideas, innovation and research

Our philosophy

The GRIP (Group for Research in Intensive care in Pavia) is founded in 2015 by a group of intensivists working at Intensive Care Units of Policlinico S. Matteo in Pavia. We are a group of young doctors and researchers who dedicated in the last years great energy, enthusiasm and time to develop new ideas, improve technology and optimize quality of care for critical patients. Our group is characterized by strong international connections for both clinical research and technological developement. Our missions are:


  1. 1

    Intensive care units are highly technological; therefore, development of innovative instruments and optimization of existing ones can have a deep clinical impact. We have strong national and international collaborations with research and development sections of industries involved in the field and with many universities in order to push technology forward.

  2. 2

    Our aim is to promote and support a research projects gripping the real world. First, this means we support research with high clinical impact and strong everyday applicability. Second, we support researchers, offering work possibilities for young professionals.

  3. 3

    We aim to share our ideas, projects and results with scientific community; we have strong national and international research cooperation and  researcher exchange programs with multiple university centers.

Impact of SARS-CoV-2 Omicron and Delta variants in patients requiring intensive care unit (ICU) admission for COVID-19, Northern Italy, December 2021 to January 2022


This multicenter observational study included 171 COVID-19 adult patients hospitalized in the ICUs of nine hospitals in Lombardy (Northern Italy) from December, 1st 2021, to February, 9th 2022. During the study period, the Delta/Omicron variant ratio of cases decreased with a delay of two weeks in ICU patients compared to that in the community; a higher proportion of COVID-19 unvaccinated patients was infected by Delta than by Omicron whereas a higher rate of COVID-19 boosted patients was Omicron-infected. A higher number of comorbidities and a higher comorbidity score in ICU critically COVID-19 inpatients was positively associated with the Omicron infection as well in vaccinated individuals. Although people infected by Omicron have a lower risk of severe disease than those infected by Delta variant, the outcome, including the risk of ICU admission and the need for mechanical ventilation due to infection by Omicron versus Delta, remains uncertain. The continuous monitoring of the circulating SARS-CoV-2 variants remains a milestone to counteract this pandemic. Respir Med Res. 2023 Mar 3;83:100990. doi: 10.1016/j.resmer.2023.100990.

Pain therapy part 1

By admin 29/03/2023
Residency lectures

Speaker Prof. Natoli



LIGHTS: le infezioni fungine - Highlights in terapia intensiva

By Silvia Mongodi 18/04/2023
Conferences and courses


Aula Didattica - SC Anestesia e Rianimazione 1a

Padiglione 43,Torre A, piano -1 - Fondazione IRCCS Policlinico San Matteo



08.00 Registrazione dei partecipanti

08.30 Presentazione degli obiettivi formativi del Corso

Bruno Viaggi, Federico Capra Marzani, Francesco Mojoli


09.00 La pratica nel reparto di Terapia Intensiva del Centro di Pavia

Federico Capra Marzani, Francesco Mojoli, Bruno Viaggi

13.00 Lunch break


14.00 Farmacologia clinica degli antifungini

Federico Pea (in collegamento sincrono da remoto)

14.30 Come tratto le infezioni fungine invasive del paziente critico:

dall’evidenza alla pratica clinica

Pierluigi Viale (in collegamento sincrono da remoto)

15.00 Ruolo di amfotericina B liposomiale in ICU

Bruno Viaggi

15.40 Discussione interattiva

16.00 Take home messages e conclusioni

Bruno Viaggi